Tekla Life Sciences Investors Stock

$14.95

0.33% yesterday

NYSE, Sep 27, 10:10 pm CET

ISIN

US87911K1007

Symbol

HQL

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Finances

Industry

Financial service provider

Overview Dividends Analysts Charts News Strategies

Tekla Life Sciences Investors Stock price

$14.95

-0.12 0.83% 5Y

NYSE, Closing price Fri, Sep 27 2024

-0.05 0.33%

ISIN

US87911K1007

Symbol

HQL

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Finances

Industry

Financial service provider

Key metrics

Market capitalization	$411.38m
Enterprise Value	$397.54m
EV/Sales (TTM) EV/Sales	13.55
P/S ratio (TTM) P/S ratio	14.02
Dividend yield	9.07%
Last dividend (FY24)	$1.36
Revenue growth (TTM) Revenue growth	-6.90%
Revenue (TTM) Revenue	$29.34m
EBIT (operating result TTM) EBIT	$38.81m
EPS (TTM) EPS	$1.41

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Get Started for Free Today

Tekla Life Sciences Investors Stock Analysis

Unlock Scores for Free

??

Financial data from Tekla Life Sciences Investors

Income Statement P&L | Balance Sheet | Cash Flow

TTM Annually

Mar '24		+/- %
Revenue	29 29	7% 7% 100%
- Direct Costs	5.12 5.12	3% 3% 17%
Gross Profit	24 24	8% 8% 83%
- Selling and Administrative Expenses	-	-
- Research and Development Expense	- -	- -
EBITDA	39 39	607% 607% 132%
- Depreciation and Amortization	- -	- -
EBIT (Operating Income) EBIT	39 39	606% 606% 132%
Net Profit	39 39	606% 606% 132%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Tekla Life Sciences Investors Stock News

Neutral

Accesswire

●

about 2 months ago

abrdn U.S. Closed-End Funds Announce Distribution Payment Details

PHILADELPHIA, PA / ACCESSWIRE / August 9, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:ACP)(NYSE:ASGI)(NYSE:AWP)(NYSE:HQH)(NYSE:HQL)(NYSE:IFN)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE American:FAX)(NYSE American:FCO)(NYSE American:IAF)(NYSE American:VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on August...

Neutral

Accesswire

●

3 months ago

abrdn U.S. Closed-End Funds Announce Distribution Payment Details

PHILADELPHIA, PA / ACCESSWIRE / June 28, 2024 / PHILADELPHIA, PA / ACCESSWIRE / June 28, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE:HQH)(NYSE:HQL)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE American:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on June 28, 2024, on a per share basis to all shareholders of reco...

Positive

Seeking Alpha

●

4 months ago

Finding Opportunities In The Closed-End Fund World

Closed-end funds have unique features that make them very attractive investment vehicles for the right asset classes and investors who understand them. Especially for complex and/or less liquid asset classes, like corporate senior loans, high-yield bonds, collateralized loan obligations, and the more recently discovered (by retail investors) "private credit" Activist and institutional investors...

More Tekla Life Sciences Investors News

Company Profile

Tekla Life Sciences Investors operates as a closed-end investment fund or Investment trust. The firm engages in the investment in the life sciences industry. It invests in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals and healthcare information technology and services. The company was founded on February 20, 1992 and is headquartered in Boston, MA.

Head office	United States
CEO	Dan Omstead
Founded	1992
Website	www.teklacap.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now